1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (1694)
  2. Journal Article (1416)
  3. Review (80)
  4. Editorial (56)
  5. Book Section (35)
  6. Guidelines (24)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)

More Groups

People
  1. Mark Kris (869)
  2. Alexander Drilon (631)
  3. Gregory Riely (599)
  4. Charles Rudin (488)
  5. Marc Ladanyi (414)
  6. Matthew Hellmann (411)

More People

Years
  1. 2025 (73)
  2. 2024 (270)
  3. 2023 (272)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (692)
  2. Journal of Thoracic Oncology (513)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (156)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (769)
  2. Elsevier Inc. (734)
  3. American Association for Cancer Research (383)
  4. Oxford University Press (350)
  5. Nature Publishing Group (148)
  6. Elsevier Science, Inc. (78)

More Publishers

Results (3351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival outcomes among young small cell lung cancer (SCLC) patients and insurance status: A SEER analysis 2007-2014
    Meeting Abstract

    Wang, Q.; Zhang, Y.; Jiang, C.; Kunte, S.; Gupta, M.; Deng, L.; Xiao, Z.; Liu, Y.; Perimbeti, S.; Daly, R. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Correlation of degree of tumor immune infiltration and insertion-and-deletion (indel) burden with outcome on programmed death 1 (PD1) therapy in advanced renal cell cancer (RCC)
    Meeting Abstract

    Voss, M. H.; Novik, J. B.; Hellmann, M. D.; Ball, M.; Hakimi, A. A.; Miao, D.; Margolis, C.; Horak, C.; Wind-Rotolo, M.; De Velasco, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Acquired BRAF fusions as a mechanism of resistance to EGFR therapy
    Meeting Abstract

    Vojnic, M.; Kurzatkowski, C.; Kubota, D.; Suzawa, K.; Liu, Z.; Mattar, M.; Khodos, I.; Poirier, J. T.; de Stanchina, E.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials
    Meeting Abstract

    Tao, J.; Eubank, M. H.; Pamer, E.; Cangemi, N. A.; Drilon, A. E.; Harding, J. J.; Schram, A. M.; Smyth, L. M.; Jhaveri, K. L.; Li, B. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prognostic relevance of tumor sequencing in metastatic lung adenocarcinomas
    Meeting Abstract

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M. D.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; Arbour, K. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Initial results from a multicenter study (LCMC3)
    Meeting Abstract

    Rusch, V. W.; Chaft, J. E.; Johnson, B.; Wistuba, I. I.; Kris, M. G.; Lee, J. M.; Bunn, P. A.; Kwiatkowski, D. J.; Reckamp, K. L.; Finley, D. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of advanced pulmonary large cell neuroendocrine carcinoma stratified by RB1 loss, SLFN11 expression, and tumor mutational burden
    Meeting Abstract

    Sabari, J. K.; Julian, R. A.; Ni, A.; Halpenny, D.; Hellmann, M. D.; Drilon, A. E.; Li, B. T.; Poirier, J. T.; Rudin, C. M.; Rekhtman, N.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC
    Meeting Abstract

    Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab (Nivo) + ipilimumab (Ipi) vs platinum-doublet chemotherapy (Chemo) as first-line (1L) treatment (Tx) for advanced non-small cell lung cancer (NSCLC): Safety analysis and patient-reported outcomes (PROs) from CheckMate 227
    Meeting Abstract

    Reck, M.; Hellmann, M. D.; Paz-Ares, L. G.; Ramalingam, S. S.; Brahmer, J. R.; O'Byrne, K. J.; Bhagavatheeswaran, P.; Nathan, F. E.; Borghaei, H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save